Salignostics is leading the future of diagnostics, delivering accessible, rapid, and reliable saliva-based solutions for global healthcare providers, home-testing markets, and laboratories. Our advanced technology makes testing faster, safer, and more cost-effective than ever.
At the core of Salignostics’ success is a team of globally recognized experts in saliva diagnostics, biomedical engineering, and healthcare innovation. With over 50 years of combined research experience and 20 years of building successful partnerships, our leadership drives groundbreaking innovations in the field of diagnostics.
Our team has published 50+ peer-reviewed articles, won 15 international awards, and secured 8 prestigious grants from the Israel Innovation Authority. In 2024, we were recognized as one of Time magazine’s 100 Most Influential in Healthcare and were the only saliva diagnostics company to reach the final stage of NIH’s RADx Initiative for COVID-19.